THE SEQUENCE OF CIRCULARLY PERMUTATED HUMAN ASRGL1 IS DESIGNED WITH ORIGINAL N- AND C- TERMINAL ...THE SEQUENCE OF CIRCULARLY PERMUTATED HUMAN ASRGL1 IS DESIGNED WITH ORIGINAL N- AND C- TERMINAL CONNECTED BY A FLEXIBLE LINKER GAGSGAGSGAGG AND WITH ORIGINAL ACTIVE SITE NUCLEOPHILE THR168 EXPOSED AS THE 1ST RESIDUE AT N- TERMINAL. SIX HISTIDING TAG DESIGNED AT C- TERMINAL. THE ORIGINAL SEQUENCE PRIOR TO PERMUTATION IS AS FOLLOWING: MTVGAVALDCKGNVAYATSTGGIVNKMVGRVGDSPCLGAGGYADNDIGAVSTTGHGESIL KVNLARLTLFHIEQGKTVEEAADLSLGYMKSRVKGLGGLIVVSKTGDWVAKWTSTSMPWA AAKDGKLHFGIDPDDTTITDLP GAGSGAGSGAGG NPIVVVHGGGAGPISKDRKERVHQGM VRAATVGYGILREGGSAVDAVEGAVVALEDDPEFNAGCGSVLNTNGEVEMDASIMDGKDL SAGAVSAVQCIANPIKLARLVMEKTPHCFLTDQGAAQFAAAMGVPEIPGEKLVTERNKKR LEKEKHEKGAQKTDCQKNLGHHHHHH
-
実験情報
-
実験
実験
手法: X線回折 / 使用した結晶の数: 1
-
試料調製
結晶
マシュー密度: 3.57 Å3/Da / 溶媒含有率: 65.52 %
結晶化
温度: 277 K / 手法: 蒸気拡散法, シッティングドロップ法 詳細: 17% PEG3350, 0.15M Tri-Potassium Citrate, Microseeding, VAPOR DIFFUSION, SITTING DROP, temperature 277K